Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Treasury Shares (2022 - 2024)

Historic Treasury Shares for TransMedics (TMDX) over the last 3 years, with Q4 2024 value amounting to $430250.0.

  • TransMedics' Treasury Shares rose 3102.76% to $430250.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $430250.0, marking a year-over-year increase of 3102.76%. This contributed to the annual value of $430250.0 for FY2024, which is 3102.76% up from last year.
  • As of Q4 2024, TransMedics' Treasury Shares stood at $430250.0, which was up 3102.76% from $328366.0 recorded in Q4 2023.
  • TransMedics' 5-year Treasury Shares high stood at $430250.0 for Q4 2024, and its period low was $24315.0 during Q4 2022.
  • Over the past 3 years, TransMedics' median Treasury Shares value was $328366.0 (recorded in 2023), while the average stood at $260977.0.
  • In the last 5 years, TransMedics' Treasury Shares soared by 125046.68% in 2023 and then soared by 3102.76% in 2024.
  • Over the past 3 years, TransMedics' Treasury Shares (Quarter) stood at $24315.0 in 2022, then soared by 1250.47% to $328366.0 in 2023, then soared by 31.03% to $430250.0 in 2024.
  • Its Treasury Shares stands at $430250.0 for Q4 2024, versus $328366.0 for Q4 2023 and $24315.0 for Q4 2022.